BRPI0407421A - Combination therapy for the treatment of immunoinflammatory disorders - Google Patents

Combination therapy for the treatment of immunoinflammatory disorders

Info

Publication number
BRPI0407421A
BRPI0407421A BR0407421-1A BRPI0407421A BRPI0407421A BR PI0407421 A BRPI0407421 A BR PI0407421A BR PI0407421 A BRPI0407421 A BR PI0407421A BR PI0407421 A BRPI0407421 A BR PI0407421A
Authority
BR
Brazil
Prior art keywords
treatment
combination therapy
nsidi
immunoinflammatory
immunoinflammatory disorders
Prior art date
Application number
BR0407421-1A
Other languages
Portuguese (pt)
Inventor
Edward Roydon Jost-Price
Bradley B Brasher
Todd W Chappell
Palaniyandi Manivasakam
Noah Sachs
Brendan Smith
Benjamin A Auspitz
Original Assignee
Combinatorx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combinatorx Inc filed Critical Combinatorx Inc
Priority claimed from PCT/US2004/004077 external-priority patent/WO2004073614A2/en
Publication of BRPI0407421A publication Critical patent/BRPI0407421A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TERAPIA COMBINADA PARA O TRATAMENTO DE DISTúRBIOS IMUNOINFLAMATóRIOS". A invenção refere-se a um método para tratar um paciente com diagnóstico de um distúrbio imunoinflamatório, ou com risco de desenvolver o mesmo, administrando-se um imunossupressor não-esteróide dependente de imunofilina (NsIDI) e um intensificador de NSIDI (NsIDIE) ou análogo ou metabólito do mesmo ao paciente. A invenção também refere-se a uma composição farmacêutica contendo um NsIDI e um NsIDIE ou análogo ou metabólíto do mesmo para o tratamento ou a prevenção de um distúrbio imunoinflamatório."COMBINED THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS". The invention relates to a method of treating a patient diagnosed with or at risk of developing an immunoinflammatory disorder by administering an immunophilin-dependent non-steroidal immunosuppressant (NsIDI) and an NSIDI enhancer (NsIDIE) or analog or metabolite to the patient. The invention also relates to a pharmaceutical composition containing an NsIDI and an NsIDIE or analog or metabolite thereof for treating or preventing an immunoinflammatory disorder.

BR0407421-1A 2003-02-14 2004-02-12 Combination therapy for the treatment of immunoinflammatory disorders BRPI0407421A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US44764803P 2003-02-14 2003-02-14
US44733603P 2003-02-14 2003-02-14
US44755303P 2003-02-14 2003-02-14
US44741203P 2003-02-14 2003-02-14
US44741503P 2003-02-14 2003-02-14
US46475303P 2003-04-23 2003-04-23
US50302603P 2003-09-15 2003-09-15
PCT/US2004/004077 WO2004073614A2 (en) 2003-02-14 2004-02-12 Combination therapy for the treatment of immunoinflammatory disorders

Publications (1)

Publication Number Publication Date
BRPI0407421A true BRPI0407421A (en) 2006-01-24

Family

ID=35610307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407421-1A BRPI0407421A (en) 2003-02-14 2004-02-12 Combination therapy for the treatment of immunoinflammatory disorders

Country Status (1)

Country Link
BR (1) BRPI0407421A (en)

Similar Documents

Publication Publication Date Title
MXPA05008649A (en) Combination therapy for the treatment of immunoinflammatory disorders.
BRPI0415397A (en) methods and reagents for the treatment of immunoinflammatory disorders
SG146653A1 (en) Methods and reagents for the treatment of immunoinflammatory disorders
DE60331236D1 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DIABETES
TW200711649A (en) Combination therapy for the treatment of immunoinflammatory disorders
WO2005020972A3 (en) Combination therapy for the treatment of ocular neovascular disorders
DE69809558D1 (en) SELECTION METHOD FOR POTENTIAL AGAINST OBESITY TO REGULATE THE UCP-2
MY176938A (en) 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
UA86344C2 (en) Normal;heading 1;heading 2;METHOD OF TREATING VASCULAR DISEASE
BR9813524A (en) Processes for treating toxicities associated with administering a therapeutic agent to a mammal, for treating toxicities associated with a mammal's exposure to radiation therapy, for treating neuro- or nephrodisturbs in a human, and for treating disorders and clinical symptoms associated with type i or type ii diabetes in a human
DE60327771D1 (en) GLP-1 AND TREATMENT METHOD FOR DIABETES
BR0015974A (en) Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound
EA200500782A1 (en) TREATMENT OF HEMORRHAGIC SHOCK
HUP0102203A2 (en) Use of optically pure(+)-norcisapride for producing pharmaceutical compositions suitable for treating apnea, bulimia and other disorders
BR0213100A (en) Combinations for the treatment of immunoinflammatory disorders
BR0314713A (en) Processes and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines.
BR0310061A (en) Methods for treating respiratory diseases and conditions with a selective inhibitor of inos and a inhibitor of pde and their compositions
DE602004031631D1 (en) USE OF BETAIN FOR THE TREATMENT OF CLAUDICATIO INTERMITTENS
BRPI0416591A (en) methods and reagents for the treatment of inflammatory disorders
UA89753C2 (en) Use of a modafinil and an antidepressant for the treatment of depression and for decreasing the onset time of an antidepressant
ATE399543T1 (en) NEW SYNERGISTIC COMPOSITION CONTAINING ROFLUMILAST AND FORMOTEROL
BRPI0407421A (en) Combination therapy for the treatment of immunoinflammatory disorders
BR0311180A (en) Methods for treating respiratory diseases and conditions using a selective inhibitor of inos
JP2004514698A (en) Method of treatment involving administration of substance P
ATE399544T1 (en) SYNERGISTIC COMPOSITION CONTAINING ROFLUMILAST AND (R,R)-FORMOTEROL

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.